BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1248 related articles for article (PubMed ID: 36106706)

  • 1. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
    Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
    J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the Neuroprotective Effects of Naringenin: Pharmacological Targets, Signaling Pathways, Molecular Mechanisms, and Clinical Perspective.
    Nouri Z; Fakhri S; El-Senduny FF; Sanadgol N; Abd-ElGhani GE; Farzaei MH; Chen JT
    Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31684142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteolin: Nature's promising warrior against Alzheimer's and Parkinson's disease.
    Goyal A; Solanki K; Verma A
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23619. PubMed ID: 38091364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Targets Underlying the Neuroprotective Effects of Boswellic Acid: A Systematic Review.
    Khaafi F; Javadi B
    Mini Rev Med Chem; 2023; 23(19):1912-1925. PubMed ID: 36998129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective Potential of Hesperidin as Therapeutic Agent in the Treatment of Brain Disorders: Preclinical Evidence-based Review.
    Bansal K; Singh V; Singh S; Mishra S
    Curr Mol Med; 2024; 24(3):316-326. PubMed ID: 36959141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exendin-4: A potential therapeutic strategy for Alzheimer's disease and Parkinson's disease.
    Verma A; Chaudhary S; Solanki K; Goyal A; Yadav HN
    Chem Biol Drug Des; 2024 Jan; 103(1):e14426. PubMed ID: 38230775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naringin and Naringenin Polyphenols in Neurological Diseases: Understandings from a Therapeutic Viewpoint.
    Emran TB; Islam F; Nath N; Sutradhar H; Das R; Mitra S; Alshahrani MM; Alhasaniah AH; Sharma R
    Life (Basel); 2022 Dec; 13(1):. PubMed ID: 36676048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Icariin: A Potential Neuroprotective Agent in Alzheimer's Disease and Parkinson's Disease.
    Khezri MR; Ghasemnejad-Berenji M
    Neurochem Res; 2022 Oct; 47(10):2954-2962. PubMed ID: 35802286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer's Disease and Parkinson's Disease.
    Nakajima A; Ohizumi Y
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naringenin: its chemistry and roles in neuroprotection.
    Atoki AV; Aja PM; Shinkafi TS; Ondari EN; Awuchi CG
    Nutr Neurosci; 2024 Jun; 27(6):637-666. PubMed ID: 37585716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Potential of Natural Products in Treating Neurodegenerative Disorders and Their Future Prospects and Challenges.
    Rahman MH; Bajgai J; Fadriquela A; Sharma S; Trinh TT; Akter R; Jeong YJ; Goh SH; Kim CS; Lee KJ
    Molecules; 2021 Sep; 26(17):. PubMed ID: 34500759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer's and Parkinson's Diseases.
    Javed H; Mohamed Fizur NM; Jha NK; Ashraf GM; Ojha S
    Curr Neuropharmacol; 2023; 21(6):1421-1432. PubMed ID: 36567278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease.
    Braidy N; Behzad S; Habtemariam S; Ahmed T; Daglia M; Nabavi SM; Sobarzo-Sanchez E; Nabavi SF
    CNS Neurol Disord Drug Targets; 2017; 16(4):387-397. PubMed ID: 28474543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural Products-based Drugs: Potential Drug Targets Against Neurological Degeneration.
    Mittal P; Goyal R; Kapoor R; Wan C; Gautam RK
    Curr Neuropharmacol; 2023; 21(4):777-786. PubMed ID: 36825704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential therapeutic use of plant flavonoids in AD and PD.
    Meng-Zhen S; Ju L; Lan-Chun Z; Cai-Feng D; Shu-da Y; Hao-Fei Y; Wei-Yan H
    Heliyon; 2022 Nov; 8(11):e11440. PubMed ID: 36387565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease.
    Nowell J; Blunt E; Gupta D; Edison P
    Ageing Res Rev; 2023 Aug; 89():101979. PubMed ID: 37328112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol.
    Rahul ; Siddique YH
    CNS Neurol Disord Drug Targets; 2021; 20(4):327-342. PubMed ID: 33511932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective Role of Phytochemicals.
    Velmurugan BK; Rathinasamy B; Lohanathan BP; Thiyagarajan V; Weng CF
    Molecules; 2018 Sep; 23(10):. PubMed ID: 30262792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unveiling Nature's potential: Promising natural compounds in Parkinson's disease management.
    Bhusal CK; Uti DE; Mukherjee D; Alqahtani T; Alqahtani S; Bhattacharya A; Akash S
    Parkinsonism Relat Disord; 2023 Oct; 115():105799. PubMed ID: 37633805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.